These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 16335923)
1. N-picolyl derivatives of Kemp's triamine as potential antitumor agents: a preliminary investigation. Regino CA; Torti SV; Ma R; Yap GP; Kreisel KA; Torti FM; Planalp RP; Brechbiel MW J Med Chem; 2005 Dec; 48(25):7993-9. PubMed ID: 16335923 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and potent antitumor activities of novel 1,3,5-cis,cis-triaminocyclohexane N-pyridyl derivatives. Chong HS; Torti SV; Ma R; Torti FM; Brechbiel MW J Med Chem; 2004 Oct; 47(21):5230-4. PubMed ID: 15456266 [TBL] [Abstract][Full Text] [Related]
3. Nickel(II), copper(II) and zinc(II) binding properties and cytotoxicity of tripodal, hexadentate tris(ethylenediamine)--analogue chelators. Ye N; Park G; Przyborowska AM; Sloan PE; Clifford T; Bauer CB; Broker GA; Rogers RD; Ma R; Torti SV; Brechbiel MW; Planalp RP Dalton Trans; 2004 May; (9):1304-11. PubMed ID: 15252622 [TBL] [Abstract][Full Text] [Related]
4. Tumor cell cytotoxicity of a novel metal chelator. Torti SV; Torti FM; Whitman SP; Brechbiel MW; Park G; Planalp RP Blood; 1998 Aug; 92(4):1384-9. PubMed ID: 9694727 [TBL] [Abstract][Full Text] [Related]
5. Tailoring the local environment around metal ions: a solution chemical and structural study of some multidentate tripodal ligands. Matyuska F; Szorcsik A; May NV; Dancs Á; Kováts É; Bényei A; Gajda T Dalton Trans; 2017 Jul; 46(26):8626-8642. PubMed ID: 28650056 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of copper chelation agents as anti-angiogenic therapy. Camphausen K; Sproull M; Tantama S; Sankineni S; Scott T; Ménard C; Coleman CN; Brechbiel MW Bioorg Med Chem; 2003 Sep; 11(19):4287-93. PubMed ID: 12951159 [TBL] [Abstract][Full Text] [Related]
8. Novel chelating agents for potential clinical applications of copper. Ma D; Lu F; Overstreet T; Milenic DE; Brechbiel MW Nucl Med Biol; 2002 Jan; 29(1):91-105. PubMed ID: 11786280 [TBL] [Abstract][Full Text] [Related]
9. Novel cytotoxic chelators that bind iron(II) selectively over zinc(II) under aqueous aerobic conditions. Planalp RP; Przyborowska AM; Park G; Ye N; Lu FH; Rogers RD; Broker GA; Torti SV; Brechbiel MW Biochem Soc Trans; 2002 Aug; 30(4):758-62. PubMed ID: 12196188 [TBL] [Abstract][Full Text] [Related]
10. Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator. Zhao R; Planalp RP; Ma R; Greene BT; Jones BT; Brechbiel MW; Torti FM; Torti SV Biochem Pharmacol; 2004 May; 67(9):1677-88. PubMed ID: 15081867 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxic activity, X-ray crystal structures and spectroscopic characterization of cobalt(II), copper(II) and zinc(II) coordination compounds with 2-substituted benzimidazoles. Sánchez-Guadarrama O; López-Sandoval H; Sánchez-Bartéz F; Gracia-Mora I; Höpfl H; Barba-Behrens N J Inorg Biochem; 2009 Sep; 103(9):1204-13. PubMed ID: 19628280 [TBL] [Abstract][Full Text] [Related]
13. Luminescent cyclometalated iridium(III) polypyridine di-2-picolylamine complexes: synthesis, photophysics, electrochemistry, cation binding, cellular internalization, and cytotoxic activity. Lee PK; Law WH; Liu HW; Lo KK Inorg Chem; 2011 Sep; 50(17):8570-9. PubMed ID: 21834537 [TBL] [Abstract][Full Text] [Related]
14. Preliminary evaluation of the cytotoxicity of a series of tris-2-aminoethylamine (Tren) based hexadentate heterocyclic donor agents. Torti SV; Ma R; Venditto VJ; Torti FM; Planalp RP; Brechbiel MW Bioorg Med Chem; 2005 Nov; 13(21):5961-7. PubMed ID: 16115775 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand. Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861 [TBL] [Abstract][Full Text] [Related]
16. Ethylenediamine-palladium(II) complexes with pyridine and its derivatives: synthesis, molecular structure and initial antitumor studies. Zhao G; Lin H; Yu P; Sun H; Zhu S; Su X; Chen Y J Inorg Biochem; 1999 Mar; 73(3):145-9. PubMed ID: 10331244 [TBL] [Abstract][Full Text] [Related]
17. Cu(I) complexes based on cis, cis-1,3,5-tris(arylideneamino)cyclohexane ligands: synthesis, structure and CO binding. Ebrahimpour P; Cushion M; Haddow MF; Hallett AJ; Wass DF Dalton Trans; 2010 Dec; 39(45):10910-9. PubMed ID: 20967334 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of copper and zinc 2-(pyridin-2-yl)imidazo[1,2-a]pyridine complexes and their potential anticancer activity. Dam J; Ismail Z; Kurebwa T; Gangat N; Harmse L; Marques HM; Lemmerer A; Bode ML; de Koning CB Eur J Med Chem; 2017 Jan; 126():353-368. PubMed ID: 27907874 [TBL] [Abstract][Full Text] [Related]
19. Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells. Balakrishna MS; Suresh D; Rai A; Mague JT; Panda D Inorg Chem; 2010 Oct; 49(19):8790-801. PubMed ID: 20812680 [TBL] [Abstract][Full Text] [Related]
20. Interaction of an extended series of N-substituted di(2-picolyl)amine derivatives with copper(II). Synthetic, structural, magnetic and solution studies. Antonioli B; Büchner B; Clegg JK; Gloe K; Gloe K; Götzke L; Heine A; Jäger A; Jolliffe KA; Kataeva O; Kataev V; Klingeler R; Krause T; Lindoy LF; Popa A; Seichter W; Wenzel M Dalton Trans; 2009 Jun; (24):4795-805. PubMed ID: 19513491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]